Discover
ENTX
Entera Bio Ltd.
2.00
1 x 1.93
1 x 2.04
bid
ask
+
0.04
2.04%
11:36 AM
timesize
| Ytd | 3.09% | |
| 1y | 2.56% |
1.96
day range
2.04
0.91
52 week range
3.22
| Open | 1.96 | Prev Close | 1.96 | Low | 1.96 | High | 2.04 | Mkt Cap | 96.61M |
| Vol | 32.47K | Avg Vol | 1.04M | EPS | -0.27 | P/E | -7.26 | Forward P/E | -3.64 |
| Beta | 1.43 | Short Ratio | 0.54 | Inst. Own | 18.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 1.43 | 200-d Avg | 1.68 | 1yr Est | 10.00 |
| Income Statement | |||
| Operating Expenses | 3.54M | ||
| Research and Development Expense | 2.25M | ||
| Selling, General and Administrative Expense | 1.29M | ||
| Operating Income | -3.54M | ||
| Interest Expense | -34.00K | ||
| Net Income | -3.50M | ||
| Net Income Common Stock | -3.50M | ||
| Net Income Common Stock (USD) | -3.50M | ||
| Consolidated Income | -3.50M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -3.54M | ||
| Earning Before Interest & Taxes (USD) | -3.54M | ||
| Weighted Average Shares | 47.76M | ||
| Weighted Average Shares Diluted | 47.76M | ||
| Balance Sheet | |||
| Cash and Equivalents | 11.93M | ||
| Cash and Equivalents (USD) | 11.93M | ||
| Current Assets | 12.49M | ||
| Property, Plant & Equipment Net | 540.00K | ||
| Total Assets | 13.13M | ||
| Debt Current | 185.00K | ||
| Total Debt | 448.00K | ||
| Current Liabilities | 1.58M | ||
| Debt Non-Current | 263.00K | ||
| Total Liabilities | 2.44M | ||
| Accumulated Retained Earnings (Deficit) | -128.87M | ||
| Accumulated Other Comprehensive Income | 41.00K | ||
| Shareholders Equity | 10.69M | ||
| Shareholders Equity (USD) | 10.69M | ||
| Assets Non-Current | 636.00K | ||
| Total Debt (USD) | 448.00K | ||
| Liabilities Non-Current | 866.00K | ||
| Trade and Non-Trade Payables | 274.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 7.00K | ||
| Net Cash Flow from Financing | 130.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -2.96M | ||
| Issuance (Purchase) of Equity Shares | 130.00K | ||
| Net Cash Flow from Operations | -3.09M | ||
| Effect of Exchange Rate Changes on Cash | 4.00K | ||
| Share Based Compensation | 672.00K | ||